Open AccessIn Regard to “A Phase Ib Study of NUC ‐1031 in Combination with Cisplatin for the First‐Line Treatment of Patients with Advanced Biliary Tract Cancer ( ABC ‐08)”
Author(s) -
Ricci Angela Dalia,
Rizzo Alessandro,
Brandi Giovanni
Publication year - 2021
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1002/onco.13703
Subject(s) - biliary tract cancer , medicine , cisplatin , biliary tract , first line , cancer , oncology , chemotherapy , gemcitabine
This letter to the editor remarks on a recently published article on the use of NUC‐1031 and cisplatin for patients with biliary tract cancer and compares results of the landmark ABC‐02 trial.